- Todos > Medicine Information and Evidence for Policy > Medicines Policy
- Todos > Medicine Access and Rational Use > Rational Use
- Todos > Medicine Access and Rational Use > Supply Management
- Palabras clave > Amazon Malaria Initiative (AMI)
- Palabras clave > antimalarial drug resistance
- Palabras clave > antimalarials – supply and distribution
- Palabras clave > availability - antimalarial medications
- Palabras clave > malaria
- Palabras clave > malaria - control strategies
- Palabras clave > national malaria control programs
- Palabras clave > performance assessment
- Palabras clave > President's Malaria Initiative (PMI)
(2010; 121 pages)
The U.S. Agency for International Development (USAID) Latin America and Caribbean Bureau, Office of Regional Sustainable Development launched the Amazon Malaria Initiative (AMI) in 2001 as a collaborative partnership among international technical organizations and Amazon Basin countries to improve the control and treatment of malaria. The initiative’s mission is to
- (i) ensure that national malaria control programs in the Amazon Basin substantially incorporate selected best practices and
- (ii) promote lasting, evidencebased policy change in the partner countries.
The technical partners provide expertise and collaborate with the nations’ ministries of health (MOHs) and national malaria control programs to proactively address malaria prevention and control. AMI partner countries are Bolivia, Brazil, Columbia, Ecuador, Guyana, Peru, Suriname, and Venezuela (2001–2007).
The technical partners are Pan American Health Organization (PAHO), USAID/Latin America and the Caribbean (LAC) and USAID/Peru, U.S. Centers for Disease Control and Prevention (CDC), U.S. Pharmacopeia (USP/DQI), Management Sciences for Health (MSH/SPS), Links Media, and Research Triangle Institute (RTI).
AMI addressed a number of specific problems that have hindered effective malaria control and treatment in the Amazon Basin subregion.